(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(0.12%) $82.73
(0.94%) $2.05
(-0.45%) $2 347.20
(-0.81%) $27.44
(-0.15%) $960.10
(-0.20%) $0.933
(-0.32%) $10.99
(-0.54%) $0.796
(1.56%) $93.31
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 12.91%
1.76% $ 12.13
Live Chart Being Loaded With Signals
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology...
Stats | |
---|---|
Dzisiejszy wolumen | 407 474 |
Średni wolumen | 371 546 |
Kapitalizacja rynkowa | 4.43B |
EPS | $0 ( 2024-02-21 ) |
Następna data zysków | ( $0.940 ) 2024-05-01 |
Last Dividend | $0.0970 ( 2010-08-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.46 |
ATR14 | $0.00700 (0.06%) |
Wolumen Korelacja
BAUSCH HEALTH COMPANIES Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
HOM-UN.TO | 0.907 |
CJR-B.TO | 0.898 |
MTY.TO | 0.893 |
GOOS.TO | 0.885 |
ERO.TO | 0.882 |
LUN.TO | 0.88 |
LB.TO | 0.877 |
CARS.TO | 0.875 |
IGM.TO | 0.872 |
D-UN.TO | 0.871 |
10 Najbardziej negatywne korelacje | |
---|---|
QBTL.TO | -0.877 |
UNS.TO | -0.87 |
SBB.TO | -0.855 |
E.TO | -0.844 |
ABCT.TO | -0.836 |
SFC.TO | -0.822 |
THNC.TO | -0.822 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BAUSCH HEALTH COMPANIES Korelacja - Waluta/Towar
BAUSCH HEALTH COMPANIES Finanse
Annual | 2023 |
Przychody: | $8.76B |
Zysk brutto: | $6.20B (70.78 %) |
EPS: | $-1.620 |
FY | 2023 |
Przychody: | $8.76B |
Zysk brutto: | $6.20B (70.78 %) |
EPS: | $-1.620 |
FY | 2022 |
Przychody: | $8.12B |
Zysk brutto: | $5.76B (70.90 %) |
EPS: | $-0.590 |
FY | 2021 |
Przychody: | $8.43B |
Zysk brutto: | $6.04B (71.61 %) |
EPS: | $-2.64 |
Financial Reports:
No articles found.
BAUSCH HEALTH COMPANIES Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.598 | 2005-11-28 |
Last Dividend | $0.0970 | 2010-08-30 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $5.49 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.9 | -- |
Div. Sustainability Score | 4.74 | |
Div.Growth Potential Score | 3.23 | |
Div. Directional Score | 3.98 | -- |
Year | Amount | Yield |
---|---|---|
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ZEB.TO | Dividend Knight | 2023-08-29 | Monthly | 15 | 2.42% | |
SRV-UN.TO | Dividend Royal | 2023-09-20 | Monthly | 17 | 5.99% | |
HPS-A.TO | Dividend King | 2023-09-14 | Quarterly | 15 | 2.00% | |
CALL.TO | Dividend King | 2023-08-30 | Monthly | 7 | 4.59% | |
XDGH.TO | Dividend Knight | 2023-09-25 | Monthly | 8 | 1.96% | |
PIF.TO | Dividend King | 2023-08-11 | Quarterly | 9 | 3.10% | |
ESGG.TO | Dividend Junior | 2023-06-28 | Quarterly | 5 | 0.88% | |
ZPL.TO | Dividend Knight | 2023-08-29 | Monthly | 12 | 2.01% | |
THE.TO | Dividend Junior | 2023-06-28 | Quarterly | 9 | 1.44% | |
KEG-UN.TO | Dividend Royal | 2023-09-20 | Monthly | 17 | 3.95% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0685 | 1.500 | -1.370 | -2.06 | [0 - 0.5] |
returnOnAssetsTTM | -0.0219 | 1.200 | -0.731 | -0.878 | [0 - 0.3] |
returnOnEquityTTM | 0.618 | 1.500 | 4.24 | 6.36 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.301 | 0.800 | 8.50 | 6.80 | [1 - 3] |
quickRatioTTM | 0.685 | 0.800 | -0.679 | -0.543 | [0.8 - 2.5] |
cashRatioTTM | 0.220 | 1.500 | 9.89 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.819 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0.725 | 1.000 | -0.843 | -0.843 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.09 | 2.00 | 8.97 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.30 | 2.00 | 8.85 | 10.00 | [0 - 20] |
debtEquityRatioTTM | -21.91 | -1.500 | -10.00 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.708 | 1.000 | 1.537 | 1.537 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.110 | 1.000 | 9.80 | 9.80 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0489 | 1.000 | -0.839 | -0.839 | [0.2 - 2] |
assetTurnoverTTM | 0.320 | 0.800 | -1.199 | -0.959 | [0.5 - 2] |
Total Score | 4.74 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.16 | 1.000 | -0.623 | 0 | [1 - 100] |
returnOnEquityTTM | 0.618 | 2.50 | 6.30 | 6.36 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.30 | 2.00 | 9.23 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.09 | 2.00 | 8.97 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.143 | 1.500 | -4.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.125 | 1.000 | 9.37 | 0 | [0.1 - 0.5] |
Total Score | 3.23 |
BAUSCH HEALTH COMPANIES
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej